Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neurodegenerative disease. While there is currently no cure, efforts are underway to change that — and to establish better treatments.
Scientists at Lawrence Livermore National Laboratory (LLNL) and the University of California (UC) system are addressing ALS challenges and opportunities at scale by collaborating across disciplines to accelerate research and development. Toward this end, the UC Livermore Collaboration Center hosted the second annual UC ALS Workshop on May 15–16.